CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
15 Oct, 08:00 PM
NYSE NYSE
$
92. 58
+2.19
+2.4228%
After Hours
$
92. 52
-0.06 -0.0648%
112.03B Market Cap
11.4 P/E Ratio
0.64% Div Yield
12.6M Volume
7.87 Eps
$ 90.39
Previous Close
Add Transaction
Day Range
91 92.64
Year Range
69.51 110.68
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
CVS Trading Well Below Wall Street Targets After Month's Softening Creates Opening

CVS Trading Well Below Wall Street Targets After Month's Softening Creates Opening

CVS trades at a forward multiple that screams cheap, yet the street's already bullish and our model runs even hotter. Before you trust either read, there are a few risks that could turn this setup into a trap.

247wallst | 4 weeks ago
CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights

CVS Health (CVS) Suffers a Larger Drop Than the General Market: Key Insights

CVS Health (CVS) concluded the recent trading session at $94.43, signifying a -1.17% move from its prior day's close.

Zacks | 4 weeks ago
Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth

Here's How CVS' Health Services Arm Is Positioned for Long-Term Growth

CVS Health's Health Services arm is gaining from pharmacy strength and improving care delivery, with robust new sales and clinic economics supporting growth.

Zacks | 1 month ago
Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?

Should You Buy, Hold or Sell CVS Stock Amid Consumer Wellness Growth?

CVS is benefiting from pharmacy growth, AI investments and a discounted valuation, but reimbursement pressure and regulatory scrutiny remain key risks.

Zacks | 1 month ago
CVS Health: Buy The Pullback Before Earnings Power Ramps Up

CVS Health: Buy The Pullback Before Earnings Power Ramps Up

CVS Health trades at a discounted 12x forward P/E versus peers, despite robust business momentum and integrated healthcare assets. Q2 2026 saw 7% YoY revenue growth to $106B and 35% adjusted operating income growth, signaling a turnaround in earnings power. Aetna margin restoration, specialty pharmacy growth, and GLP-1 expansion offset risks from elevated medical costs and regulatory headwinds.

Seekingalpha | 1 month ago
CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom

CVS Health Eyes Margin Recovery, Cash Flow as 2027 Headwinds Loom

CVS Health NYSE: CVS executives said the company is seeing improved momentum across its insurance, pharmacy, care delivery and balance-sheet priorities, while maintaining a cautious outlook on healthcare cost trends and several 2027 headwinds.

Marketbeat | 1 month ago
Here's Why CVS Health (CVS) is a Strong Momentum Stock

Here's Why CVS Health (CVS) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 month ago
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know

Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.

Zacks | 1 month ago
CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?

CVS Health (CVS) Up 1% Since Last Earnings Report: Can It Continue?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 month ago
Here's Why CVS Health (CVS) is a Strong Growth Stock

Here's Why CVS Health (CVS) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 month ago
Here's How CVS' Improving Balance Sheet Supports Deleveraging

Here's How CVS' Improving Balance Sheet Supports Deleveraging

CVS Health's strong cash generation, higher operating cash flow outlook and disciplined capital deployment support continued deleveraging in 2026.

Zacks | 1 month ago
Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Why CVS Health (CVS) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 1 month ago
Loading...
Load More